Julie Grant
Director/Board Member presso Nocion Therapeutics, Inc.
Profilo
Julie Grant was the founder of Day One Biopharmaceuticals, Inc. (founded in 2018) and served as an Independent Director from 2022 to 2023.
Ms. Grant is also the founder of DOT Therapeutics-2, Inc...
Ms. Grant's current job(s) include being a Director at Protagonist Pty Ltd., Nocion Therapeutics, Inc., Synthekine, Inc., and General Partner at Canaan Management, Inc. Ms. Grant's former job(s) include being an Independent Director at Protagonist Therapeutics, Inc. from 2015 to 2017, Principal at Genentech, Inc. and Labrys Biologics, Inc., and a Board Member at Biden Cancer Initiative, Inc. from 2017 to 2018.
Ms. Grant's education history includes a graduate degree from the University of Cambridge in 2006, an undergraduate degree from Yale University in 2005, and an MBA from Stanford Graduate School of Business in 2013.
Posizioni attive di Julie Grant
| Società | Posizione | Inizio |
|---|---|---|
Canaan Management, Inc.
 Canaan Management, Inc. Investment ManagersFinance Canaan Management, Inc. (Canaan Management) is a venture capital firm founded in 1987 by Eric A. Young. The firm is headquartered in Westport, CT. | Private Equity Analyst | 01/01/2013 |
Protagonist Pty Ltd.
 Protagonist Pty Ltd. Pharmaceuticals: MajorHealth Technology Protagonist Pty Ltd. operates as a clinical-stage biopharmaceutical company. Its proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The company was founded on September 19, 2001 and is headquartered in Brisbane, Australia. | Director/Board Member | - |
Nocion Therapeutics, Inc.
 Nocion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nocion Therapeutics, Inc. is a biopharmaceutical company, which targets neurons mediating cough, itch, pain and inflammation without the addictive properties of opioids. The company was founded by Bruce Bean, Clifford Woolf and Bruce David Levy and is headquartered in Cambridge, MA. | Director/Board Member | 01/02/2018 |
Synthekine, Inc.
 Synthekine, Inc. BiotechnologyHealth Technology Synthekine, Inc. engages as a biotechnology company. The company is headquartered in Menlo Park, CA. | Director/Board Member | 01/03/2019 |
Precedenti posizioni note di Julie Grant
| Società | Posizione | Fine |
|---|---|---|
| DAY ONE BIOPHARMACEUTICALS, INC. | Chief Executive Officer | 01/09/2020 |
| Biden Cancer Initiative, Inc. | Director/Board Member | 01/11/2018 |
| PROTAGONIST THERAPEUTICS, INC. | Director/Board Member | 14/12/2017 |
DOT Therapeutics-2, Inc.
 DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | Founder | - |
Labrys Biologics, Inc.
 Labrys Biologics, Inc. BiotechnologyHealth Technology Labrys Biologics, Inc. provides biotechnology services. It is a venture-financed development stage biotechnology company, which focuses on treatments for chronic migraine. The company was founded by Corey S. Goodman in 2012 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | - |
Formazione di Julie Grant
| University of Cambridge | Graduate Degree |
| Yale University | Undergraduate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Health Technology |
| DAY ONE BIOPHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 8 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Protagonist Pty Ltd.
Protagonist Pty Ltd. Pharmaceuticals: MajorHealth Technology Protagonist Pty Ltd. operates as a clinical-stage biopharmaceutical company. Its proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The company was founded on September 19, 2001 and is headquartered in Brisbane, Australia. | Health Technology |
Labrys Biologics, Inc.
Labrys Biologics, Inc. BiotechnologyHealth Technology Labrys Biologics, Inc. provides biotechnology services. It is a venture-financed development stage biotechnology company, which focuses on treatments for chronic migraine. The company was founded by Corey S. Goodman in 2012 and is headquartered in San Francisco, CA. | Health Technology |
Canaan Management, Inc.
Canaan Management, Inc. Investment ManagersFinance Canaan Management, Inc. (Canaan Management) is a venture capital firm founded in 1987 by Eric A. Young. The firm is headquartered in Westport, CT. | Finance |
Nocion Therapeutics, Inc.
Nocion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nocion Therapeutics, Inc. is a biopharmaceutical company, which targets neurons mediating cough, itch, pain and inflammation without the addictive properties of opioids. The company was founded by Bruce Bean, Clifford Woolf and Bruce David Levy and is headquartered in Cambridge, MA. | Health Technology |
Synthekine, Inc.
Synthekine, Inc. BiotechnologyHealth Technology Synthekine, Inc. engages as a biotechnology company. The company is headquartered in Menlo Park, CA. | Health Technology |
| Biden Cancer Initiative, Inc. | |
DOT Therapeutics-2, Inc.
DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Julie Grant
